Kindstar Globalgene Technology(“KG”) is the leader in providing specialty clinical laboratory tests and services in China. The company has a strong technology and commercial platform in hematology, tumor and routine pathology, and molecular diagnostics. The company was founded in Wuhan in 2003, and in 2011 it signed a strategic collaboration agreement with the Mayo Clinic to deploy new esoteric testing capabilities throughout Kindstar’s network in China. The resulting company is well-positioned to grow nationally. As the only sizable company focusing on providing specialty clinical tests in China, KG has established an excellent reputation among its peers and customers.
Learn more: http://www.kindstar.com.cn/kindstar/cn/